Drawing for CELLS FOR PERSONALISED MEDICINE

USPTO serial 79346038

CELLS FOR PERSONALISED MEDICINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SINGH, DEEP K
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CELLS FOR PERSONALISED MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for scientific or research use; chemical reagents for non-medical purposes; reagents for in vitro use; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus; biomarkers; test kits for scientific or research useACTIVE—
005Diagnostic reagents and assay components for clinical, medical and medical laboratory use; diagnostic kits comprised of diagnostic reagents and assay components for clinical, medical and medical laboratory use; not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnosticsACTIVE—
009Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use; apparatus, equipment and instruments for cytology, histology and for use in detecting medical diseases and disorders, not for medical use, and all for laboratory use, diagnostic or general research use; apparatus in the nature of cassettes for use in laboratory, diagnostic or general research use; cell analyser providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus and equipment for use in testing and analysing tissue, blood, cells and plasma not for medical use, and all for laboratory use, diagnostic or general research use; reagent kits not for medical use and all for laboratory use; biological analysis computer software; parts and fitting for the aforesaid goodsACTIVE—
010Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases; medical testing apparatus, equipment and instruments; medical testing kits; testing kits for use in laboratory analysis and clinical diagnosis; parts and fittings for the aforesaid goodsACTIVE—
042Biological, scientific and medical research and consultation services related thereto; product research and development in the fields of biology and medical sciences; custom development of biochemical reagents; services of a chemical laboratory; services of a medical laboratory, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; advice and information relating to the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 4, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 15, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 14, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 21, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 3, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 13, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 13, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 13, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 3, 2023DOCKASSIGNED TO EXAMINER—
Jan 10, 2023RFNPREFUSAL PROCESSED BY IB—
Dec 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 21, 2022RFRRREFUSAL PROCESSED BY MPU—
Oct 8, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 7, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Aug 2, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance